- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Artificial Respiration.
Displaying page 1 of 1.
EudraCT Number: 2004-001529-88 | Sponsor Protocol Number: LOC 04/2004-01 | Start Date*: 2004-11-08 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Dose efficacy relation of inhalative prostaglandin I2 vs. inhalative prostaglandin E1 in patients with ARDS: comparison of efficacy with respect to paO2/FiO2 ratio, Qs/Qt and PAP. | ||
Medical condition: Patients suffering from ARDS who need in the moment of enrolment artificial respiration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-005430-37 | Sponsor Protocol Number: | Start Date*: 2015-01-02 | |||||||||||
Sponsor Name:North Bristol NHS Trust | |||||||||||||
Full Title: Use of co-trimoxazole to prevent pneumonia in patients with severe head injury | |||||||||||||
Medical condition: Pneumonia secondary to severe head injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001276-20 | Sponsor Protocol Number: USA107212 | Start Date*: 2006-12-05 |
Sponsor Name:GlaxoSmithKline GmbH & Co. KG | ||
Full Title: A randomized, open-label, multicenter, parallel-group study to compare the efficacy, safety and resource utilization of a remifentanil/propofol analgosedation regimen versus a sufentanyl/propofol a... | ||
Medical condition: Ventilated patients under intensive medical care with an expected duration of analgosedation of up to 7 days | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-001650-26 | Sponsor Protocol Number: AnticholiumperSeIII | Start Date*: 2014-04-28 | |||||||||||
Sponsor Name:Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D | |||||||||||||
Full Title: A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium®) as adjunctive measure in perioperative sepsis/septic shock | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002090-12 | Sponsor Protocol Number: Ilocard | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Hospital of the university of munich | |||||||||||||
Full Title: Effect of Iloprost inhalation before and during extracorporeal circulation (ECC) on perioperative morbidity and outcome in high risk cardiac surgical patients | |||||||||||||
Medical condition: In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.